World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02627222
Date of registration: 08/12/2015
Prospective Registration: No
Primary sponsor: Wageningen University
Public title: The Efficacy of Pro-vitamin A Biofortified Cassava on Vitamin A Status in Nigerian Preschool Children CASSAVITA II
Scientific title: The Efficacy of Pro-vitamin A Biofortified Cassava on Vitamin A Status in Nigerian Preschool Children
Date of first enrolment: December 2015
Target sample size: 176
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02627222
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Single (Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Nigeria
Contacts
Name:     Alida Melse-Boonstra, PhD
Address: 
Telephone:
Email:
Affiliation:  Division of Human Nutrition, Wageningen University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Aged 36 - 59 months (verified by birth certificates, vaccination cards or other formal
documentation)

- Apparently healthy

- Parental informed consent

Exclusion Criteria:

- Frequently absent (>20% of feeding days) during run-in

- Children not assenting during blood collections

- Signs or history of infectious or systemic diseases (e.g. tuberculosis, sickle cell
anaemia)

- Mental status that is incompatible with the proper conduct of the study

- Current participation in other research

- Food allergy related to the intervention foods



Age minimum: 36 Months
Age maximum: 59 Months
Gender: All
Health Condition(s) or Problem(s) studied
Vitamin A Deficiency
Intervention(s)
Other: White cassava
Other: Pro-vitamin A biofortified cassava
Primary Outcome(s)
Body retinol pool (omitted) [Time Frame: 13 weeks]
(Modified primary outcome): Serum retinol [Time Frame: 13 weeks]
Secondary Outcome(s)
Anaemia [Time Frame: 13 weeks]
Gut integrity [Time Frame: 11 weeks]
Secondary ID(s)
CASSAVITA II
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
International Institute for Tropical Agriculture
University of Ibadan
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history